Why biological data matters more in AI drug discovery

GSK has entered into a research collaboration with British biotechnology company Relation Therapeutics worth up to $110 million, expanding the companies’ existing work in AI-assisted drug discovery.

Under the agreement, Relation will generate large-scale datasets measuring how human cells…